MOS
MGO One Seven Portfolio holdings
AUM
$3.1B
This Quarter Return
+6.72%
1 Year Return
+19.06%
3 Year Return
+73.35%
5 Year Return
+137.41%
10 Year Return
–
AUM
$214M
AUM Growth
–
Cap. Flow
+$214M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
18.7%
Holding
357
New
357
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Charles Schwab
SCHW
|
$6.08M |
| 2 |
Apple
AAPL
|
$4.86M |
| 3 |
Microsoft
MSFT
|
$4.7M |
| 4 |
First Trust Dorsey Wright Focus 5 ETF
FV
|
$4.49M |
| 5 |
JPMorgan Chase
JPM
|
$4.37M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Financials | 13.55% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 8.42% |
| 4 | Communication Services | 7.55% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EOD
351
Allspring Global Dividend Opportunity Fund
EOD
$244M
| $56K | 0.03% |
+10,731
| New | +$56K |
|
|
HIO
352
Western Asset High Income Opportunity Fund
HIO
$374M
| $56K | 0.03% |
+11,893
| New | +$56K |
|
353
Celsius Holdings
CELH
$15.8B
| $46K | 0.02% |
+34,500
| New | +$46K |
|
354
Marchex
MCHX
$87.5M
| $44K | 0.02% |
+16,140
| New | +$44K |
|
|
DMK
355
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $37K | 0.02% |
+152
| New | +$37K |
|
356
Plus Therapeutics
PSTV
$45.7M
| $4K | ﹤0.01% |
+15
| New | +$4K |
|
|
RGLS
357
DELISTED
Regulus Therapeutics
RGLS
| $4K | ﹤0.01% |
+200
| New | +$4K |
|